|
Status |
Public on Jun 16, 2010 |
Title |
MMTV-Wnt/ILK tumor rep4 |
Sample type |
RNA |
|
|
Source name |
Mammary tumor tissue from double-transgenic MMTV-Wnt/ILK mouse.
|
Organism |
Mus musculus |
Characteristics |
tissue: mammary fat pad gender: female parity: nulliparous transgenic strain: MMTV-Wnt/ILK
|
Growth protocol |
Nulliparous females were monitored bi-weekly for the appearance of a small palpable tumor nodule in the mammary fat pads.
|
Extracted molecule |
total RNA |
Extraction protocol |
1 μg of RNA was used as starting material and rRNA reduced using the RiboMinus Transcriptome Isolation Kit (Invitrogen) as per Affymetrix recommendations.
|
Label |
biotin
|
Label protocol |
Total RNA was extracted from snap frozen tumor tissue using the GeneChip Whole Transcript (WT) Sense Target (ST) Labeling Assay (Affymetrix) as per manufacturer’s recommendations before being hybridized to a GeneChip Mouse Exon 1.0 ST Array (Affymetrix).
|
|
|
Hybridization protocol |
Samples were hybridized with GeneChip Mouse Exon 1.0 ST Arrays (Affymetrix) and scanned at the CTAG Facility of the British Columbia Cancer Agency, Vancouver, BC, Canada.
|
Scan protocol |
Array scanning was performed according to the manufacturer's instructions (Affymetrix)
|
Description |
RMA expression value derived from ArrayAssist version 5.0 software; core-exon and gene level analysis
|
Data processing |
CEL files were processed using ArrayAssist 5.0. Targets showing absolute fold change greater than 1.5 and p-value < 0.05 were assessed for further investigation.
|
|
|
Submission date |
Dec 03, 2009 |
Last update date |
Jun 16, 2010 |
Contact name |
Steven McKinney |
E-mail(s) |
[email protected]
|
Phone |
604-675-8000
|
Organization name |
British Columbia Cancer Agency
|
Department |
Molecular Oncology
|
Lab |
Samuel Aparicio
|
Street address |
675 West 10th Ave
|
City |
Vancouver |
State/province |
BC |
ZIP/Postal code |
V5Z 1L3 |
Country |
Canada |
|
|
Platform ID |
GPL6096 |
Series (1) |
GSE19300 |
Activation of ER-alpha network in MMTV-Wnt/ILK mammary tumors |
|